Francis Cano

Francis Cano (board member) discloses dealings in 2 companies, chiefly Biomerica Inc and Dynavax Technologies Corp. In total, 49 filings cover trades dated from 25 May 2007 to 10 February 2026.

In open-market terms, that means 31 purchases worth €172k on one side and 3 sales worth €311k on the other. Sales outweigh purchases by €138k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants and 8 option exercises.

The median purchase comes to €2,320. Clusters matter here: 21 out of 21 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 23 purchases with a full 90-day history, the hit rate stands at 13% and the median 90-day move at -24.3%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 10 February 2026, the filings show a transaction in Dynavax Technologies Corp. The clock since the last published purchase (12 August 2019) now reads 2,645 days. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.